GAIASO appoints Dr. Tracey Brown as CEO
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Maria Soler Nunez appointed as Chief Quality Officer
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Subscribe To Our Newsletter & Stay Updated